Posters on the Podium

Discover More

Formulation and Characterization of Powders for Inhalation using an Antitussive API to Treat Cough in Idiopathic Pulmonary Fibrosis
Carlotta Giulieri
Aptuit, an Evotec Company
Effect of Adding an Inhaler Training Device and Smartphone Application to Traditional Verbal Counseling in Asthmatic Patients
Sara Tony
Beni-Suef University
Nebulization Of Mucolytic Agent – MESNA – Using Different Nebulizer Technologies With Adult And Child Breathing Patterns
Edgar Hernan Cuevas Brun
HCmed Innovations
JW
Evaluating Aerosol Drug Deposition During Exacerbation And Healthy Breathing Using Medical Image-based Models
Josh Williams
Heriot-Watt University
Understanding Particle Friability Through Solid State Characterization
Ruben Chaves
Hovione
Comparison of Two Drug Micronization Methods Using Multiple Physiochemical Characterization Techniques
Sara Perico
Hovione
Amorphous Solid Dispersions For Nasal Delivery: Development, Characterization And Performance Studies
Patricia Henriques
Hovione
Evaluation Of The Pharmacokinetic Profile Of Inhaled Treprostinil Palmitil Inhalation Powder (TPIP) In Rats
Zhili Li
Insmed
A Long Nozzle For Intra-nasal Drug Delivery By pMDI: Prediction Of Spray Velocity And Droplet Size
Barzin Gavtash
Kindeva Drug Delivery
Unravelling DPI Aerosol Performance Using In-Vitro Deposition And Particle Image Velocimetry
Vishal Chaugule
Monash University
Predicting The Regional Deposition And Systemic Exposure Of Albuterol Sulfate Formulated With Low Global Warming Potential Propellants
Will Ganley
Nanopharm, an Aptar Pharma Company
Stressed And Accelerated Storage Of Pressurized Metered Dose Inhalers With Various Valve Types To Explore The Impact On Aerosol Performance Characteristics And Product Quality Attributes
Irene Rossi
Nanopharm, an Aptar Pharma Company
CM
Designing A Model Dry Powder Formulation For Aptar Prohaler®: The Influence of Fine Lactose And Force Control Agent
Irene Rossi and Cyrine Mestiri
Nanopharm, an Aptar Pharma Company
Simulation of Transient Inhalation Profile Including Aerosol Evolution and Deposition in an Upper Respiratory Airway Geometry
Francesco Lucci
Philip Morris International
In Vitro Testing And Human Pharmacokinetic Predictions Of Inhaled Chloroquine And Hydroxychloroquine To Treat Severe Acute Respiratory Syndrome Coronavirus 2
Aditya Reddy Kolli
Philip Morris International
Pairwise Analysis Of The Effect Of Clinically Relevant Conditions On The Fine Particle Dose Of Bronchodilator From Metered Dose Inhaler With Valved Holding Chamber Combinations
Lois Slator
Philips Respironics
AL
An Indirect Pharmacokinetic Comparison Of Cannabidiol Formulations: Dry Power Inhaler (DPI) Vs Vaporization
Andrea Leone-Bay
Receptor Life Sciences
Using Inhalation To Bypass First-pass Metabolism As A Means Of Improving Cannabidiol Bioavailability
Kelly Kraft
Receptor Life Sciences
Diverse Approaches Of Carrier Particle Engineering For Dry Powder Inhalers
Sarah Zellnitz
Research Center Pharmaceutical Engineering
Repurposing Bedaquiline by Inhalation for Non-small Cell Lung Cancer
Vineela Parvathaneni
St. John's University
Continuous Production Of Nebulized Antibiotic Formulation For Treatment Of Pseudomonas Aeruginosa Infections In Cystic Fibrosis
Gautam Chauhan
St. John's University
Aerosolized Nanoliposomal Carrier of Remdesivir (AL‑Rem) - A Potential Alternative to the Existing Covid-19 Treatment
Richa Vartak
St. John's University
Bioinspired Particle Engineering For Non-invasive Drug Delivery To The Lungs – Influence Of Particle Shape
Snehal Shukla
St. John's University
Four Steps To Selecting The ‘Right’ Device To Deliver A New Therapy
Charlotte Harris
Team Consulting
A Laboratory-based Examination of the Potential for Fugitive Emission of Aerosols to the Local Environment from a Range of Commercially Available Nebulizer Systems
Mark Nagel
Trudell Medical International
A Comparison, Using Functional Respiratory Imaging (FRI), Of Adult Airway Deposition Profiles From a pMDI With Valved Holding Chamber (pMDI/VHC) And Two DPIs
Jason Suggett
Trudell Medical International
Naloxone Intranasal Solution: Stability and Nasal Permeability Challenges
Manar Al-Ghabeish
U.S. Food & Drug Administration
Understanding The Dispersibility Enhancement Of L‑leucine In The Spray Drying Of Inhalable Microparticles
Mani Ordoubadi
University of Alberta
Influence Of Airway Epithelial Cells In Alveolar Macrophage Responses To Inhaled Substances In Vitro
Victoria Hutter
University of Hertfordshire
Co-Spray Dried Powder Inhalation Formulations of Antimicrobial Peptide and Capreomycin for Combating Drug-Resistant Tuberculosis
Zitong Shao
University of Hong Kong
AS
Modeling Specific Crystal Faces Of Solid Particles In MDI Formulations
Vivian Barron and Alex Slowey
University of Leeds
FM
Development Of Inhalable Plasminogen For Potential Use In Pulmonary Coagulopathy
Anna Maria Piras and Filippo Mori
University of Pisa / Kedrion
TH
Preparation and Physicochemical Characterization of Novel Ciprofloxacin Salts
Thomas Hibbard
University of Reading
Effect Of Carrier Size And Property on Adhesive Unit for Inhalation: A Numerical Investigation
Sohan Sarangi
Uppsala University
Inhalable Heparin Formulations To Treat Cystic Fibrosis: A Vibrating Mesh Nebulizer And A Dry Powder Inhaler Comparison
Mireia Puig and Daniel Lock
Vectura Fertin Pharma
Dual-chamber Microfluidic Platform To Study Biofilm Susceptibility In Air-liquid And Liquid-liquid Interfaces
Ye Zhang
Woolcock Institute of Medical Research
Use Of Cnicin, A Sesquiterpene Lactone, as a Treatment For Lung Inflammation In COPD
Dina Silva
Woolcock Institute of Medical Research
The Effect of Processing Technique on Inhaled Particle Morphology and Adhesion
Metin Karabulut
World Medicine
CO-ORGANIZERS
CONFERENCE SUPPORTERS
↑ Back to Top